Yueming Wang
Senior Principal Scientist & Leader - Clinical Pharmacology Johnson & Johnson Innovative Medicine.
Seminars
Wednesday 18th November 2026
Designing the Path, Driving the Impact
9:00 am
- Exploring a strategic, case-based perspective on how MIDD connects evidence, learning, and decisions across development; from translational evidence and first-inhuman strategy through adaptive dose and regimen optimization to proof-of-concept planning
- Explaining how using complex oncology biologics to illustrate how quantitative insights can shape the development path
